NDC 58602-810 – Guaifenesin

Guaifenesin 600 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC58602-810

Product details

Brand name
Guaifenesin
Generic name
Guaifenesin
Labeler
Aurohealth LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210453
Marketed since
October 21, 2019
Listing expires
December 31, 2026
Pharmacologic class
Expectorant

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin →

Package NDC codes (7)

Package NDCDescriptionSince
58602-810-121 BOTTLE in 1 CARTON (58602-810-12) / 40 TABLET, EXTENDED RELEASE in 1 BOTTLEOct 21, 2019
58602-810-211 BOTTLE in 1 CARTON (58602-810-21) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLEOct 21, 2019
58602-810-388 BLISTER PACK in 1 CARTON (58602-810-38) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKDec 7, 2022
58602-810-731 BOTTLE in 1 CARTON (58602-810-73) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLEOct 21, 2019
58602-810-961 BLISTER PACK in 1 CARTON (58602-810-96) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKOct 21, 2019
58602-810-972 BLISTER PACK in 1 CARTON (58602-810-97) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKOct 21, 2019
58602-810-985 BLISTER PACK in 1 CARTON (58602-810-98) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACKOct 21, 2019

Other Guaifenesin products